There are many conditions that can cause serious, life-threatening blood clots in our bodies. Luckily, there are treatment options that are available to help prevent blood clots from occurring. It’s important to know that some of these options may put your health at serious risk while offering minimal benefits.
Take, for instance, inferior vena cava (IVC) filters. IVC filters are small, web-like devices that are inserted into an artery in the body in order to catch and break up blood clots before they can make their way to the lungs, heart, or brain, which can cause serious adverse health events like strokes and heart attacks.
The problem with the device is that it can easily malfunction, and at least one new study shows the devices may be ineffective. According to an article from Medscape, researchers have found that a using a combination of IVC filters and anticoagulant drugs in no more effective than simply using the medication to treat a patient.
The team used concealed randomization in order to ensure the confidentiality of the treatment each patient was receiving. They concluded the use of an IVC filter plus an anticoagulant offered no better results in preventing embolisms in patients after three months than just using an anticoagulant medication.
If you’ve been harmed as the result of having an IVC filter implanted into your body, you may have a right to compensation and discussing your case with a qualified legal representative may be wise. Our team of defective medical device lawyers at Fleschner, Stark, Tanoos & Newlin are available anytime to answer any questions you may have.
Fleschner, Stark, Tanoos & NewlinN/a
The financial burden that often comes with a serious injury can be too much for many people to bear. Unexpected medical debt, damaged personal property, and the sudden loss of income can impact the budgets of most families. The good news is that a successful injury claim could help reduce that financial strain after a serious accident. Get in touch with a Terre Haute personal injury lawyer with Fleschner, Stark, Tanoos & Newlin to learn more.
© Fleschner, Stark, Tanoos & Newlin